Comparison MoonLake Immunotherapeutics (MLTX) with Competitors
MoonLake Immunotherapeutics (MLTX) industry is Biotechnology.
Debt-to-Equity
MLTX38.98%
Industry29.76%
Upside+30.98%
Free Cash Flow Yield
MLTX-17.08%
Industry-1.94%
Upside-15.14%
P/E
MLTX-5.14
Industry-18.88
Upside+1373.97%
P/B
MLTX5.56
Industry4.70
Upside+18.36%